dc.contributor.author |
Iványi, G |
|
dc.contributor.author |
Zelkó, Romána |
|
dc.date.accessioned |
2019-09-10T16:20:31Z |
|
dc.date.available |
2019-09-10T16:20:31Z |
|
dc.date.issued |
2017 |
|
dc.identifier |
85011299943 |
|
dc.identifier.citation |
journalVolume=55;journalIssueNumber=2;journalTitle=INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS;pagerange=133-137;journalAbbreviatedTitle=INT J CLIN PHARM TH; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/7598 |
|
dc.identifier.uri |
doi:10.5414/CP202705 |
|
dc.format.extent |
133-137 |
|
dc.title |
Post-authorization changes in the safety and efficacy assessment, recommended indications and drug quality profile of adalimumab: A chronological overview |
|
dc.type |
Journal Article |
|
dc.date.updated |
2019-09-05T20:07:26Z |
|
dc.language.rfc3066 |
en |
|
dc.rights.holder |
NULL |
|
dc.identifier.mtmt |
3107985 |
|
dc.identifier.wos |
000392439100004 |
|
dc.identifier.pubmed |
27900937 |
|
dc.contributor.department |
SE/GYTK/Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet |
|
dc.contributor.institution |
Semmelweis Egyetem |
|